Dr. Datasons Labs Ltd.
NSE: DRDATSONS | BSE: 533412
₹6.40
As on 21-May-2015IST
Market cap
₹69 Cr
Revenue (TTM)
₹507 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0.1 %
-
ROCE
5 %
-
Industry P/E
39.9
-
EV/EBITDA
15.3
-
Debt to Equity
1.2
-
Book Value
₹--
-
EPS
₹-1.9
-
Face value
10
-
Shares outstanding
109,583,406
8 Years Aggregate
CFO
₹57.16 Cr
EBITDA
₹383.31 Cr
Net Profit
₹100.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Datasons Labs
| -35.0 | -57.3 | -4.5 | -65.8 | -76.9 | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2014
|
|---|---|
|
Dr. Datasons Labs
| -86.8 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr. Datasons Labs
|
6.4 | 68.9 | 507.4 | -6.1 | 2.1 | -1.3 | -- | 0.1 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Dr. Datasons Labs
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
2006
-
Chairman
--
-
Managing Director
Rajendra Kamat
-
Headquarters
Raigad Dist, Maharashtra
-
Website
Looking for more details about Dr. Datasons Labs Ltd.’s IPO? Explore our IPO Details page.
FAQs for Dr. Datasons Labs
What is the current share price of Dr Datasons Labs Ltd Today?
The share price of Dr Datasons Labs Ltd is ₹6.40 (NSE) and ₹6.29 (BSE) as of 21-May-2015 IST. Dr Datasons Labs Ltd has given a return of -76.9% in the last 3 years.
What is the current PB & PE ratio of Dr Datasons Labs Ltd?
Since, TTM earnings of Dr Datasons Labs Ltd is negative, P/E ratio is not available.
The P/B ratio of Dr Datasons Labs Ltd is 0.11 times as on 21-May-2015, a 97 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2014 |
276.13 |
0.33 |
2013 |
430.29 |
0.59 |
2012 |
18.50 |
2.17 |
2011 |
0.00 |
0.00 |
2010 |
0.00 |
0.00 |
What is the 52 Week High and Low of Dr Datasons Labs Ltd?
The 52-week high and low of Dr Datasons Labs Ltd are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Dr Datasons Labs Ltd?
Dr Datasons Labs Ltd has a market capitalisation of ₹ 69 Cr as on 21-May-2015. As per SEBI classification, it is a company.
Should I invest in Dr Datasons Labs Ltd?
Before investing in Dr Datasons Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.